ArticleCancer communications (London, England)2019

Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.